Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

Company Overview - Optinose is a specialty pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists [3] - The company will present a business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference on May 20, 2024 [1] Event Details - The presentation will take place at NASDAQ at 11:30 a.m. ET [1] - A replay of the webcast will be available for 30 days following the event [2] Investor Relations - For further inquiries, Optinose's investor contact is Jonathan Neely, reachable at jonathan.neely@optinose.com or 267.521.0531 [4]